Challenge to the developmental study of new biomarker and new treatment in recalcitrant allergic skin disease
Challenge to the developmental study of new biomarker and new treatment in recalcitrant allergic skin disease
批准号:
21591471
负责人:
IKEZAWA Zenro
金额:
$3.0万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1) IL-18 levels in the horny layer were significantly higher in the skin lesions of patients with AD than in healthy controls and correlated with SCORAD, levels of serum IL-18, IgE, lactate dehydrogenase(LDH), thymus and activation-regulated chemokine(TARC), blood eosinophils and transepidermal water loss(TEWL). In the AD group with serum IgE<1500 IU mL, significantly higher IL-18 levels were observed in the horny layer of patients colonized with S. aureus compared with those who were not. From these results, it may be concluded that epidermal IL-18 production is associated with the severity of AD, that staphylococcus aureus colonization seems to contribute to this IL-18 production, especially in the AD group with relatively low IgE production, and that tape stripping provides an easy and noninvasive method to assess epidermal IL-18 production by ELISA. 2-1) Pruritus is a common symptom of psoriasis, which affects quality of life. This symptom accompanies the hyperinnervation of sensor … More y C-fibres in psoriatic lesions. Two extracellular molecules, nerve growth factor(NGF) and semaphorin-3A, regulate C-fibre extension. In this study, the expression levels of these 2 molecules in biopsy specimens from psoriatic and healthy skin were quantified by immune-histochemistry and quantitative reverse-transcription PCR. Semaphorin-3A expression was lower in the psoriatic samples compared with the healthy samples, whereas NGF was higher. C-fibre innervation in the epidermis was also increased in psoriatic skin. Semaphorin-3A mRNA expression was negatively correlated with itch intensity and severity of psoriasis. We propose that decreased semaphorin-3A and increased NGF expression levels may trigger the outgrowth of C-fibres, leading to pruritus. 2-2) Sneezing and persistent itching of the nasal mucosa are distressing symptoms of allergic rhinitis(AR). Recent studies have revealed that hyperinnervation of sensory neurons in the nasal turbinate is one of the underlying causes of sneezing and itching. Since Semaphorin-3A(Sema3A) has been previously shown to restrict innervation of sensory neurons, it is presumed that reduced Sema3A expression in the nasal mucosa might contribute to the hypersensitivity. Analysis of the mouse model of ovalbumin-sensitized AR demonstrated a decreased expression of Sema3A in the nasal epithelium, which was accompanied by an increased nerve fiber density in the lamina propria of the turbinate. In rescue experiments, intranasal administration of recombinant Sema3A in the AR model mice alleviated sneezing and nasal rubbing symptoms. In addition, histological examinations also revealed that nerve fiber density was decreased in the lamina propria of the Sema3A-treated nasal turbinate. These results suggest that the nasal hypersensitivity of AR may be attributed to reduction of Sema3A expression and intranasal administration of Sema3A may provide a novel approach to alleviate the allergic symptoms for AR treatment. 3) CTP enhanced hyaluronic acid production in human dermal fibroblasts in vitro and in murine skin in vivo. Oral administration of CTP in acetone-induced dry skin model mice significantly decreased TEWL and suppressed scratching behavior. Intraepidermal nerve growth was dramatically inhibited in CTP-treated mice. Quantitative PCR analysis and immunohistochemical study revealed that CTP abolished the increased NGF and decreased Sema3A levels induced by acetone treatment. From these results, it may be concluded that oral administration of CTP improves dry skin and normalizes axon-guidance factors in the epidermis in addition to reducing pruritus. CTP may be used in a new therapeutic strategy against dry skin and pruritus. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
血管性浮腫の診断と治療の進歩
血管性水肿的诊断和治疗进展
DOI:
--
发表时间:
2011
期刊:
臨床免疫・アレルギー科
影响因子:
--
作者:
[岡安寛明、尾関祐二, 他, 池澤善郎]
通讯作者:
池澤善郎
Interleukin-18 is elevated in the horny layer in patients with atopic dermatitis and is associated with Sraphylococcus aureus colonization(E-Poster Gold prize)
特应性皮炎患者角质层中白细胞介素 18 升高,与金黄色葡萄球菌定植有关(电子海报金奖)
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Inoue Y, Aihara M, Kirino M, Komori-Yamaguchi J, Yamaguchi Y, Nagashima Y, Ikezawa Z]
通讯作者:
Ikezawa Z
O5-4.フィラグリン遺伝子変異を有する乳幼児アトピー性皮膚炎におけるスキンケア有用性の検討
O5-4. 丝聚蛋白基因突变婴儿特应性皮炎皮肤护理有效性的检查
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[井上雄介, 蒲原毅, 中河原玲子, 田中貴美代, 関和男, 榎本久子, 野口恵美子, 相原道子, 池澤善郎]
通讯作者:
池澤善郎
Decreased expression of semaphorin3A in the lesional skin of psoriasis vulgaris with itch
伴有瘙痒的寻常型银屑病皮损皮肤中semaphorin3A表达降低
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Kou K, Nakamura F, Aihara M, Seto K, Komori J, Kambara T, Nagashima Y, Goshima Y, Ikezawa Z]
通讯作者:
Ikezawa Z
重症薬疹におけるステロイドパルス療法(シンポジウム)
类固醇脉冲疗法治疗严重药疹(研讨会)
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[池澤優子, 相原道子, 松倉節子, 山根裕美子, 蒲原毅, 池澤善郎]
通讯作者:
池澤善郎
共 69 条
Developmental study of new biomarker and new treatment in recalcitrant allergic skin disease
-
批准号:19591320
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:IKEZAWA Zenro
-
依托单位:
A study of pathomechanism of drug/metal allergy by oral administration
-
批准号:04807074
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1992
-
负责人:IKEZAWA Zenro
-
依托单位:
A Study of Autoreactive T Cells in Drug-Induced Autoimmune Skin Disease
-
批准号:01570570
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1989
-
负责人:IKEZAWA Zenro
-
依托单位:
海外基金